81_FR_41710 81 FR 41587 - Center for Scientific Review; Notice of Closed Meetings

81 FR 41587 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 123 (June 27, 2016)

Page Range41587-41588
FR Document2016-15055

Federal Register, Volume 81 Issue 123 (Monday, June 27, 2016) 
[Federal Register Volume 81, Number 123 (Monday, June 27, 2016)]
[Notices]
[Pages 41587-41588]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-15055]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Urologic and Urogynecologic Small Business Applications.
    Date: July 13-14, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Ryan G. Morris, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 
20892, 301-435-1501; [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Bacterial and Eukaryotic Molecular Genetics.
    Date: July 13, 2016.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Ronald Adkins, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 2206, MSC 7890, Bethesda, MD 20892; 301-435-
4511; [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; R15 AREA Grant Review.
    Date: July 13, 2016.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Michael M. Sveda, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD 
20892; 301-435-3565; [email protected]

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; CIDR Conflict Review.
    Date: July 15, 2016.
    Time: 11:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Richard Panniers, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2212, MSC 7890, Bethesda, MD 
20892; (301) 435-1741; [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Cell Biology, Developmental Biology and 
Bioengineering.
    Date: July 18-19, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Alexander Gubin, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of

[[Page 41588]]

Health, 6701 Rockledge Drive, Room 4196, MSC 7812, Bethesda, MD 
20892; 301-435-2902; [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 21, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-15055 Filed 6-24-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 123 / Monday, June 27, 2016 / Notices 41587 Time: 8:00 a.m. to 6:00 p.m. Name of Committee: Center for Scientific This notice is being published less than 15 Agenda: To review and evaluate grant Review Special Emphasis Panel; Member days prior to the meeting due to the timing applications. Conflict: Topics in Biology of Infectious limitations imposed by the review and Place: The Fairmont Washington, DC, 2401 Diseases Agents, Drug Resistance and Drug funding cycle. M Street, NW, Washington, DC 20037. Discovery. Name of Committee: Center for Scientific Contact Person: Kenneth A Roebuck, Ph.D., Date: July 21, 2016. Review Special Emphasis Panel; Member Scientific Review Officer, Center for Time: 10:00 a.m. to 5:30 p.m. Conflict: Bacterial and Eukaryotic Molecular Scientific Review, National Institutes of Agenda: To review and evaluate grant Genetics. Health, 6701 Rockledge Drive, Room 5214, applications. Date: July 13, 2016. MSC 7852, Bethesda, MD 20892, (301) 435– Place: National Institutes of Health, 6701 Time: 1:00 p.m. to 4:00 p.m. 1166,roebuckk@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892. Agenda: To review and evaluate grant Name of Committee: Center for Scientific Contact Person: Tera Bounds, DVM, Ph.D., applications. Review Special Emphasis Panel; RFA–OD– Scientific Review Officer, Center for Place: National Institutes of Health, 6701 16–003: Environmental Influences on Child Scientific Review, National Institutes of Rockledge Drive, Bethesda, MD 20892 Health Outcomes Patient Reported Outcomes Health, 6701 Rockledge Drive, Room 3214, (Telephone Conference Call). Research Resource Core (ECHO PRO). MSC 7808, Bethesda, MD 20892, 301–435– Contact Person: Ronald Adkins, Ph.D., Date: July 19, 2016. 2306, boundst@csr.nih.gov. Scientific Review Officer, Center for Time: 10:00 a.m. to 12:00 p.m. (Catalogue of Federal Domestic Assistance Scientific Review, National Institutes of Agenda: To review and evaluate grant Program Nos. 93.306, Comparative Medicine; Health, 6701 Rockledge Drive, Room 2206, applications. 93.333, Clinical Research, 93.306, 93.333, MSC 7890, Bethesda, MD 20892; 301–435– Place: National Institutes of Health, 6701 93.337, 93.393–93.396, 93.837–93.844, 4511; ronald.adkins@nih.gov. Rockledge Drive, Bethesda, MD 20892, 93.846-93.878, 93.892, 93.893, National This notice is being published less than 15 (Telephone Conference Call). Institutes of Health, HHS) days prior to the meeting due to the timing Contact Person: Heidi B Friedman, Ph.D., Dated: June 21, 2016. limitations imposed by the review and Scientific Review Officer, Center for Natasha M. Copeland, funding cycle. Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1012A, Program Analyst, Office of Federal Advisory Name of Committee: Center for Scientific MSC 7770, Bethesda, MD 20892, 301–379– Committee Policy. Review Special Emphasis Panel; R15 AREA 5632, hfriedman@csr.nih.gov. [FR Doc. 2016–15056 Filed 6–24–16; 8:45 am] Grant Review. Date: July 13, 2016. Name of Committee: Center for Scientific BILLING CODE 4140–01–P Time: 12:00 p.m. to 2:00 p.m. Review Special Emphasis Panel; Member Agenda: To review and evaluate grant Conflict: Genetics of Diseases. applications. Date: July 19, 2016. DEPARTMENT OF HEALTH AND Place: National Institutes of Health, 6701 Time: 1:00 p.m. to 3:30 p.m. HUMAN SERVICES Rockledge Drive, Bethesda, MD 20892 Agenda: To review and evaluate grant (Telephone Conference Call). applications. National Institutes of Health Contact Person: Michael M. Sveda, Ph.D., Place: National Institutes of Health, 6701 Scientific Review Officer, Center for Rockledge Drive, Bethesda, MD 20892 Center for Scientific Review; Notice of Scientific Review, National Institutes of (Telephone Conference Call). Contact Person: Richard A Currie, Ph.D., Closed Meetings Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD 20892; 301–435– Scientific Review Officer, Center for Pursuant to section 10(d) of the 3565; svedam@csr.nih.gov Scientific Review, National Institutes of Federal Advisory Committee Act, as Health, 6701 Rockledge Drive, Room 1108, This notice is being published less than 15 MSC 7890, Bethesda, MD 20892, (301) 435– amended (5 U.S.C. App.), notice is days prior to the meeting due to the timing 1219,currieri@csr.nih.gov. hereby given of the following meetings. limitations imposed by the review and The meetings will be closed to the funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small public in accordance with the Name of Committee: Center for Scientific Business: Cell and Molecular Biology. provisions set forth in sections Review Special Emphasis Panel; CIDR Date: July 19, 2016. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Conflict Review. Time: 12:00 p.m. to 3:00 p.m. as amended. The grant applications and Date: July 15, 2016. Agenda: To review and evaluate grant the discussions could disclose Time: 11:30 a.m. to 12:30 p.m. applications. Agenda: To review and evaluate grant confidential trade secrets or commercial Place: National Institutes of Health, 6701 applications. property such as patentable material, Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. and personal information concerning Contact Person: Ross D Shonat, Ph.D., Rockledge Drive, Bethesda, MD 20892 Scientific Review Officer, Center for individuals associated with the grant (Telephone Conference Call). Scientific Review, National Institutes of applications, the disclosure of which Contact Person: Richard Panniers, Ph.D., Health, 6701 Rockledge Drive, Room 6196, would constitute a clearly unwarranted Scientific Review Officer, Center for MSC 7804, Bethesda, MD 20892, 301–435– invasion of personal privacy. Scientific Review, National Institutes of 2786, ross.shonat@nih.gov. Health, 6701 Rockledge Drive, Room 2212, Name of Committee: Center for Scientific Name of Committee: AIDS and Related MSC 7890, Bethesda, MD 20892; (301) 435– Review Special Emphasis Panel; Urologic Research Integrated Review Group; 1741; pannierr@csr.nih.gov. and Urogynecologic Small Business NeuroAIDS and other End-Organ Diseases Applications. Name of Committee: Center for Scientific Study Section. Date: July 13–14, 2016. Review Special Emphasis Panel; Date: July 21–22, 2016. Time: 8:00 a.m. to 5:00 p.m. Fellowships: Cell Biology, Developmental Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant Biology and Bioengineering. Agenda: To review and evaluate grant applications. Date: July 18–19, 2016. applications. Place: National Institutes of Health, 6701 Time: 8:00 a.m. to 5:00 p.m. mstockstill on DSK3G9T082PROD with NOTICES Place: The Fairmont Washington, DC, 2401 Rockledge Drive, Bethesda, MD 20892 Agenda: To review and evaluate grant M Street, NW, Washington, DC 20037. (Virtual Meeting). applications. Contact Person: Eduardo A Montalvo, Contact Person: Ryan G. Morris, Ph.D., Place: Embassy Suites at the Chevy Chase Ph.D., Scientific Review Officer, Center for Scientific Review Officer, Center for Pavilion, 4300 Military Road NW., Scientific Review, National Institutes of Scientific Review, National Institutes of Washington, DC 20015. Health, 6701 Rockledge Drive, Room 5108, Health, 6701 Rockledge Drive, Room 4205, Contact Person: Alexander Gubin, Ph.D., MSC 7852, Bethesda, MD 20892, (301) 435– MSC 7814, Bethesda, MD 20892, 301–435– Scientific Review Officer, Center for 1168, montalve@csr.nih.gov. 1501; morrisr@csr.nih.gov. Scientific Review, National Institutes of VerDate Sep<11>2014 18:52 Jun 24, 2016 Jkt 238001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM 27JNN1

41588 Federal Register / Vol. 81, No. 123 / Monday, June 27, 2016 / Notices Health, 6701 Rockledge Drive, Room 4196, DEPARTMENT OF HEALTH AND and 37 CFR part 404 to achieve MSC 7812, Bethesda, MD 20892; 301–435– HUMAN SERVICES expeditious commercialization of 2902; gubina@csr.nih.gov. results of federally-funded research and (Catalogue of Federal Domestic Assistance National Institutes of Health development. Foreign patent Program Nos. 93.306, Comparative Medicine; applications are filed on selected 93.333, Clinical Research, 93.306, 93.333, National Eye Institute; Notice of Closed inventions to extend market coverage 93.337, 93.393–93.396, 93.837–93.844, Meeting for companies and may also be available 93.846–93.878, 93.892, 93.893, National Pursuant to section 10(d) of the for licensing and/or co-development. Institutes of Health, HHS) Federal Advisory Committee Act, as ADDRESSES: Invention Development and Dated: June 21, 2016. amended (5 U.S.C. App.), notice is Marketing Unit, Technology Transfer Natasha M. Copeland, hereby given of the following meeting. Center, National Cancer Institute, 9609 The meeting will be closed to the Medical Center Drive, Mail Stop 9702, Program Analyst, Office of Federal Advisory public in accordance with the Rockville, MD 20850–9702. Committee Policy. provisions set forth in sections FOR FURTHER INFORMATION CONTACT: [FR Doc. 2016–15055 Filed 6–24–16; 8:45 am] 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Information on licensing and co- BILLING CODE 4140–01–P as amended. The grant applications and development research collaborations, the discussions could disclose and copies of the U.S. patent confidential trade secrets or commercial applications listed below may be DEPARTMENT OF HEALTH AND property such as patentable material, obtained by contacting: Attn. Invention HUMAN SERVICES and personal information concerning Development and Marketing Unit, individuals associated with the grant Technology Transfer Center, National National Institutes of Health applications, the disclosure of which Cancer Institute, 9609 Medical Center National Eye Institute; Notice of Closed would constitute a clearly unwarranted Drive, Mail Stop 9702, Rockville, MD Meeting invasion of personal privacy. 20850–9702, Tel. 240–276–5515 or Name of Committee: National Eye Institute email ncitechtransfer@mail.nih.gov. A Pursuant to section 10(d) of the Special Emphasis Panel; NEI Clinical signed Confidential Disclosure Federal Advisory Committee Act, as Cooperative Agreement and Clinically- Agreement may be required to receive amended (5 U.S.C. App.), notice is Oriented Applications. copies of the patent applications. Date: July 28, 2016. SUPPLEMENTARY INFORMATION: hereby given of the following meeting. Time: 1:00 p.m. to 3:00 p.m. Technology description follows. The meeting will be closed to the Agenda: To review and evaluate grant Title of invention: Anti- B-Cell public in accordance with the applications. Place: National Institute of Health, 5635 Maturation Antigen Antibodies for provisions set forth in sections Developing Cancer Therapeutics Fisher Lane, Rockville, MD 20814 552b(c)(4) and 552b(c)(6), title 5 U.S.C., (Telephone Conference Call). Keywords: BCMA, Antibody, as amended. The grant applications and Contact Person: Brian Hoshaw, Ph.D., Immunotoxin, Chimeric Antigen the discussions could disclose Scientific Review Officer, National Eye Receptor (CAR), Antibody-drug confidential trade secrets or commercial Institute, National Institutes of Health, Conjugate (ADC), Bispecific Antibody, property such as patentable material, Division of Extramural Research, 5635 Cancer, Myeloma, and personal information concerning Fishers Lane, Suite 1300, Rockville, MD Description of Technology: Multiple 20892, 301–451–2020, hoshawb@ Myeloma is a subtype of leukemia that individuals associated with the grant mail.nih.gov. applications, the disclosure of which originates in bone marrow, where (Catalogue of Federal Domestic Assistance normal plasma cells are produced. would constitute a clearly unwarranted Program Nos. 93.867, Vision Research, invasion of personal privacy. Although FDA-approved antibody-based National Institutes of Health, HHS) therapy is available for other B-cell Name of Committee: National Eye Institute Dated: June 21, 2016. malignancies, no effective antibody- Special Emphasis Panel; NEI Data Analysis Natasha M. Copeland, based therapies are available for MM and Epidemiology Grant Applications. Program Analyst, Office of Federal Advisory due to the lack of specific target antigen Date: July 18–19, 2016. Committee Policy. on MM cells. BCMA (B-Cell Maturation Time: 8:00 a.m. to 5:00 p.m. [FR Doc. 2016–15063 Filed 6–24–16; 8:45 am] Antigen), is a membrane antigen Agenda: To review and evaluate grant BILLING CODE 4140–01–P selectively expressed on mature B- applications. lymphocytes and in all MM cells from Place: National Institutes of Health, 5635 patients. Thus, BCMA shows promise as Fishers Lane, Bethesda, MD 20892, (Virtual DEPARTMENT OF HEALTH AND a target for immune-based therapy. Meeting). HUMAN SERVICES This technology concerns the Contact Person: Jeanette M. Hosseini, generation of several monoclonal Ph.D., Scientific Review Officer, 5635 Fishers National Institutes of Health Lane, Suite 1300, Bethesda, MD 20892, 301– antibodies against BCMA. These 451–2020, jeanetteh@mail.nih.gov. antibodies can be utilized Government-Owned Inventions; therapeutically in several ways, (Catalogue of Federal Domestic Assistance Availability for Licensing including as recombinant Program Nos. 93.867, Vision Research, AGENCY: National Institutes of Health, immunotoxins, chimeric antigen National Institutes of Health, HHS) receptors (CARs), antibody-drug mstockstill on DSK3G9T082PROD with NOTICES HHS. Dated: June 21, 2016. ACTION: Notice. conjugates (ADCs), bispecific Natasha M. Copeland, antibodies, and as unconjugated Program Analyst, Office of Federal Advisory SUMMARY: The invention listed below is antibodies. The antibodies can also be Committee Policy. co-owned by an agency of the U.S. use in diagnostic applications. It is [FR Doc. 2016–15061 Filed 6–24–16; 8:45 am] Government and is available for important to note that several licensing and/or co-development in the conjugated immunotoxins using the BILLING CODE 4140–01–P U.S. in accordance with 35 U.S.C. 209 antibodies of this invention have VerDate Sep<11>2014 18:52 Jun 24, 2016 Jkt 238001 PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM 27JNN1


Document Created: 2016-06-25 02:06:36
Document Modified: 2016-06-25 02:06:36
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJuly 13-14, 2016.
FR Citation81 FR 41587 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR